Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xuanyu Gu

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Cancer Letters|September 27, 2024
Revisiting the CXCL13/CXCR5 axis in the tumor microenvironment in the era of single-cell omics: Implications for immunotherapyXuanyu Gu, Dongyu Li, Peng Wu, et al.
Cancer Immunology, Immunotherapy : CII|June 29, 2026
CD68<sup>+</sup> tumor-associated macrophages exhibit prognostic value in surgically resected small cell lung cancer: a retrospective cohort study of 614 patientsRuijie Ma, Hengjia Tu, Xingwu Wang, et al.
Cancer Discovery|November 1, 2024
A Call for Innovative Translational and Clinical Research to Address China's Unique Cancer LandscapeChaoqi Zhang, Peng Wu, Dongyu Li, et al.
Molecular Cancer|July 7, 2026
Autophagy in cancer - functional plasticity, therapeutic paradox, and the road to precision modulation: a comprehensive reviewJingjing Liu, Peng Wu, Dongyu Li, et al.
Medcomm|February 12, 2026
Clinical Benefit of PD-1/PD-L1 Inhibitors as Standard First-Line Treatment in Low PD-L1-Expressing Advanced Solid Tumors: A Systematic Review and Meta-AnalysisPeng Wu, Xuanyu Gu, Dongyu Li, et al.
Med (New York, N.Y.)|April 15, 2025
Efficacy and safety of anti-PD-1 versus anti-PD-L1 in perioperative immunotherapy: A comprehensive reanalysis of randomized controlled trialsChaoqi Zhang, Peng Wu, Dongyu Li, et al.
Cell Research|April 23, 2022
Discovery of small-molecule activators of nicotinamide phosphoribosyltransferase (NAMPT) and their preclinical neuroprotective activityHong Yao, Minghui Liu, Leibo Wang, et al.
Cancer Letters|June 12, 2025
Identification of an Individualized Immune-Related miRNA Pair Signature for Survival Prediction of Neoadjuvant Chemoradiotherapy in Esophageal Squamous Cell CancerPeng Wu, Dexin Shang, Li Liu, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Cancer Letters|September 27, 2024
Revisiting the CXCL13/CXCR5 axis in the tumor microenvironment in the era of single-cell omics: Implications for immunotherapyXuanyu Gu, Dongyu Li, Peng Wu, et al.
Cancer Immunology, Immunotherapy : CII|June 29, 2026
CD68<sup>+</sup> tumor-associated macrophages exhibit prognostic value in surgically resected small cell lung cancer: a retrospective cohort study of 614 patientsRuijie Ma, Hengjia Tu, Xingwu Wang, et al.
Cancer Discovery|November 1, 2024
A Call for Innovative Translational and Clinical Research to Address China's Unique Cancer LandscapeChaoqi Zhang, Peng Wu, Dongyu Li, et al.
Molecular Cancer|July 7, 2026
Autophagy in cancer - functional plasticity, therapeutic paradox, and the road to precision modulation: a comprehensive reviewJingjing Liu, Peng Wu, Dongyu Li, et al.
Medcomm|February 12, 2026
Clinical Benefit of PD-1/PD-L1 Inhibitors as Standard First-Line Treatment in Low PD-L1-Expressing Advanced Solid Tumors: A Systematic Review and Meta-AnalysisPeng Wu, Xuanyu Gu, Dongyu Li, et al.
Med (New York, N.Y.)|April 15, 2025
Efficacy and safety of anti-PD-1 versus anti-PD-L1 in perioperative immunotherapy: A comprehensive reanalysis of randomized controlled trialsChaoqi Zhang, Peng Wu, Dongyu Li, et al.
Cell Research|April 23, 2022
Discovery of small-molecule activators of nicotinamide phosphoribosyltransferase (NAMPT) and their preclinical neuroprotective activityHong Yao, Minghui Liu, Leibo Wang, et al.
Cancer Letters|June 12, 2025
Identification of an Individualized Immune-Related miRNA Pair Signature for Survival Prediction of Neoadjuvant Chemoradiotherapy in Esophageal Squamous Cell CancerPeng Wu, Dexin Shang, Li Liu, et al.
Pageof 2